Dallas-based OncoNano, raised a $12.7 million Series B venture funding from undisclosed investors. The company is developing a nanotechnology platform to enhance the effectiveness of cancer therapies in acidic tumor environments.
Error, no group ID set! Check your syntax!
OncoNano Medicine raises $12.7m Series B funding round
Share via:
[addtoany]
Error, no group ID set! Check your syntax!
